Avgol, a global leader in the manufacture of high-performance nonwoven fabric solutions, has been shortlisted for the Hygienix Innovation Award for its advanced antimicrobial solution.
beneFIT Control is a tailored ‘next-generation’ antimicrobial solution developed to aid in contamination, discomfort and odour by controlling the microbial activity within hygiene applications, including diapers, adult incontinence products and feminine care.
The adaptable, favourably coloured solution maximises the effect on troublesome organisms and has a unique, ground-breaking ability to minimise the impact on natural and normal skin flora and the environment after disposal.
“At Avgol we are passionate about developing visionary products and solutions that deliver relevant, timely and tangible value to our customers,” says Nick Carter, director, market business intelligence and intellectual property at Avgol.
“This is why we are driving forward with our Forward Innovative Thinking (FIT) strategy to deliver high-performance technologies to anticipate the needs of the baby diaper, adult incontinence and feminine hygiene markets.
“It is extremely gratifying to be recognised in these industry-renowned awards and I would like to thank every member of the Avgol team for their hard work in bringing beneFIT Control to market.”
Held annually, the Hygienix Innovation Awards recognise innovation within the entire disposable absorbent hygiene value chain that utilises nonwoven fabric or technology in a way that expands the usage of nonwovens. The winners will be announced during the annual Hygienix Conference, this year held 5-8 November at the Loews Portofino Bay Hotel in Orlando, Florida, US.
